Concepedia
Statistics
Publications
18
Citations
1.4K
H-Index
15
Active since
1995
Affiliations
University of Hong Kong(Current)
Queen Mary Hospital
FibroGen (United States)
Fate Therapeutics (United States)
The University of Texas MD Anderson Cancer Center
Carol Wong is an author at University of Hong Kong specializing in medicine, life sciences, and oncology.
Publications per year
1995–2025
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Kenneth E. Lipson, Carol Wong, Yuchin Teng et al. · Fibrogenesis & Tissue Repair · 2012 · 578 citations · Full text
Veterinary Medicine, Pathobiology, Pathology +17
HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques
Matthew M. Hsieh, Nathaniel S. Linde, Aisha Wynter et al. · Blood · 2007 · 172 citations · Full text
Medicine, Hematology, Pharmacology +8
Connective Tissue Growth Factor–Specific Monoclonal Antibody Therapy Inhibits Pancreatic Tumor Growth and Metastasis
Nadja Dornhöfer, Suzanne Spong, Kevin L. Bennewith et al. · Cancer Research · 2006 · 143 citations
Medicine, Oncology, Pharmacology +13
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
Armin Ghobadi, Veronika Bachanová, Krish Patel et al. · The Lancet · 2025 · 113 citations · Full text
Life Sciences, Immunology, Oncology +16
Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma
Veronika Bachanová, Armin Ghobadi, Krish Patel et al. · Blood · 2021 · 82 citations
Life Sciences, Immunology, Oncology +14
1–5 of 18